PHIND Seminar: Identifying Microbiome Markers of Progression of Alzheimer’s Disease

When:
November 17, 2020 @ 11:00 am – 12:00 pm
2020-11-17T11:00:00-08:00
2020-11-17T12:00:00-08:00
Where:
Zoom - See Description for Zoom Link
Cost:
Free
Contact:
Ashley Williams
PHIND Seminar: Identifying Microbiome Markers of Progression of Alzheimer’s Disease @ Zoom - See Description for Zoom Link

PHIND Seminar Series: “Identifying Microbiome Markers of Progression of Alzheimer’s Disease”

Ami Bhatt, MD
Assistant Professor of Medicine (Hematology) and of Genetics
Stanford University

 

Gavin Sherlock, PhD
Associate Professor of Genetics
Stanford University

 

11:00am – 12:00pm Seminar & Discussion
RSVP Here: https://stanford.zoom.us/webinar/register/9716040837223/WN_iBOM7R4XQjOPSb20rkUxbw

Zoom Webinar Details
Webinar URL: https://stanford.zoom.us/s/99730716280
Dial: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
Webinar ID: 997 3071 6280
Passcode: 767148

 

About Ami Bhatt
In perpetual awe of how ‘simple’ microbial organisms can perturb complex, multicellular eukaryotic organisms, Ami Bhatt has chosen to dedicate her research program to inspecting, characterizing and dissecting the microbe-human interface. Nowhere is the interaction between hosts and microbes more potentially impactful than in immunocompromised hosts and global settings where infectious and environmental exposures result in drastic and sometimes fatal health consequences.

Ami’s group identifies problems and questions that arise in the course of routine clinical care. Often in collaboration with investigators at Stanford and beyond, the group applies modern genetic, molecular and computational techniques to seek answers to these questions, better understand host-microbe interactions and decipher how perturbation of these interactions may result in human disease phenotypes.

 

Gavin Sherlock’s Research Interests
Adaptive Evolution and the Fitness Landscape: When yeast are evolved under various selective pressures in a chemostat, mutations that arise and provide an adaptive advantage will expand within the population. We have pioneered the use of high throughput sequencing to determine the identity of such mutations, as well as to understand the dynamics of the mutations within the populations, and the interactions between the mutations (such as epistasis). Further, we have developed a DNA barcode based lineage tracking system to determine the distribution of fitness effects (DFE) for newly arising beneficial mutations. We have also characterized what we call the genotype-fitness map for beneficial mutations, and have investigated why beneficial mutations provide a positive fitness effect. We are also interested in how beneficial mutations trade-off for different traits, and how those trade-offs constrain adaptive evolution.

 

Hosted by: Garry Gold, MD
Sponsored by: PHIND Center & the Department of Radiology